Company: OFIX
Filing Date: 2025-04-30
Form Type: DEFA14A
Source: 0000950170-25-061072
Chunk: 1

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEFA14A
Chunk 1
---
 and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. If you want to receive a paper or e-mail copy of the materials relating to this meeting and future shareholder meetings, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before June 4, 2025. Unless requested by this date, you will not otherwise receive a paper or e-mail copy of the proxy materials. Internet:www.investorelections.com/OFIXCall: 1-866-648-8133 Email:paper@investorelections.com* If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Your control number Have the 12 digit control number located in the box above available when you access the website and follow the instructions. SEE REVERSE FOR FULL AGENDA Copyright © 2025 BetaNXT, Inc. or its affiliates. All Rights Reserved

LOGO Orthofix Medical Inc. Annual Meeting of Shareholders THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE: FOR all the listed director nominees and FOR PROPOSALS 2 AND 3 PROPOSAL 1. Election of Directors 1.01 Alan L. Bazaar 1.02 Wayne Burris 1.03 Massimo Calafiore 1.04 Vickie L. Capps 1.05 Michael M. Finegan 1.06 Jason M. Hannon 1.07 John B. Henneman, III 1.08 Charles R. Kummeth 1.09 Shweta Singh Maniar 1.10 Michael E. Paolucci 2. Advisory and Non-Binding Vote to Approve Executive Compensation. 3. Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025.